Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital

Authors: Amelework Yilema, Feleke Moges, Sisay Tadele, Mengistu Endris, Afework Kassu, Wondwossen Abebe, Getnet Ayalew

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Enterococci become clinically important especially in immune compromised patients and important causes of nosocomial infections. Data on the prevalence, antimicrobial susceptibility patterns and associated factors of enterococci are scarce in Ethiopia.

Methods

A hospital based cross-sectional study was conducted at the University of Gondar Teaching Hospital from February 28, 2014 to May 1, 2014. Pretested structured questionnaire was used to collect socio-demographic data and possible associated factors of enterococci infections. Clinical samples including urine, blood, wound swabs and other body fluids from patients requested by physician for culture and antimicrobial susceptibility test during the study period were included. A total of 385 patients were included in the study. Data were entered and analyzed using SPSS Version 20. P values <0.05 were considered as statistically significant.

Result

The overall prevalence of enterococci infection was 6.2% (24/385). The commonest sites of infections were urinary tract followed by wound and blood. Among the 24 isolates, 33.3% (8/24) were resistant to all tested antimicrobial agents. Forty one point 7 % (10/24) of the enterococci isolates were vancomycin resistant enterococci (VRE). Moreover, two third of the isolates were multidrug resistant (MDR) enterococci. In multivariate analysis, duration of hospital stay for two days and more than two days with infection rate 17/32 (53.1%), previous history of any antibiotics (AOR = 9.13; [95% CI; 2.01–41.51] P = 0.00) and history of urinary catheterization (AOR = 8.80; [95% CI; 1.70–45.64] P = 0.01) were associated with presence of higher enterococci infections than their respective groups.

Conclusion

The prevalence of enterococci infections among patients with UTIs, wound infections and sepsis were higher than the other infections. Multi drug resistant enterococci including VRE were isolated from clinical samples in the study area. Being hospitalized for ≥48 h, having history of any antibiotic administration and catheterization were associated factors for enterococci infections. Presence of VRE indicates decreased antibiotic treatment options of multidrug resistant enterococci. Therefore, efforts should be made to prevent enterococci infections and emergency of multidrug resistant enterococci. Moreover, species identification and antibiotic resistant in advanced and at large scale is demanding.
Literature
1.
go back to reference Teixeira LM, Merquior VLC. Enterococcus. In: Molecular Typing in Bacterial Infections. New York: Springer; 2013. p. 17–26. Teixeira LM, Merquior VLC. Enterococcus. In: Molecular Typing in Bacterial Infections. New York: Springer; 2013. p. 17–26.
2.
go back to reference Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(6):1749–57.CrossRefPubMed Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(6):1749–57.CrossRefPubMed
3.
go back to reference Bereket W, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012;16(8):1039–44.PubMed Bereket W, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012;16(8):1039–44.PubMed
4.
go back to reference Akkoyun S, Kuloğlu F, Tokuc B. Etiologic agents and risk factors in nosocomial urinary tract infections. Mikrobiyoloji bulteni. 2008;42(2):245–54.PubMed Akkoyun S, Kuloğlu F, Tokuc B. Etiologic agents and risk factors in nosocomial urinary tract infections. Mikrobiyoloji bulteni. 2008;42(2):245–54.PubMed
5.
go back to reference Sood S, et al. Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008;128(2):111–21.PubMed Sood S, et al. Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008;128(2):111–21.PubMed
6.
go back to reference Hidron AI, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control & Hospital Epidemiology. 2008;29(11):996–1011.CrossRef Hidron AI, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control & Hospital Epidemiology. 2008;29(11):996–1011.CrossRef
7.
go back to reference Allegranzi B, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–41.CrossRefPubMed Allegranzi B, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–41.CrossRefPubMed
8.
go back to reference Nejad SB, et al. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ. 2011;89(10):757–65.CrossRef Nejad SB, et al. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ. 2011;89(10):757–65.CrossRef
9.
go back to reference Fernandes SC, Dhanashree B. Drug resistance & virulence determinants in clinical isolatesof Enterococcus species. Indian J Med Res. 2013;137(5):981.PubMedPubMedCentral Fernandes SC, Dhanashree B. Drug resistance & virulence determinants in clinical isolatesof Enterococcus species. Indian J Med Res. 2013;137(5):981.PubMedPubMedCentral
10.
go back to reference Abebe W, et al. Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study. BMC Public Health. 2014;14(1):1.CrossRef Abebe W, et al. Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study. BMC Public Health. 2014;14(1):1.CrossRef
11.
go back to reference Top J, et al. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect. 2007;13(3):316–9.CrossRefPubMed Top J, et al. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect. 2007;13(3):316–9.CrossRefPubMed
12.
go back to reference Vandepitte J, et al. Basic laboratory procedures in clinical bacteriology. Geneva: World Health Organization; 2003. Vandepitte J, et al. Basic laboratory procedures in clinical bacteriology. Geneva: World Health Organization; 2003.
13.
go back to reference Program, C.o.P.S.o.S.L.Q.A. Procedures/guidelines for the microbiology laboratory; 2010. p. 15–60. Program, C.o.P.S.o.S.L.Q.A. Procedures/guidelines for the microbiology laboratory; 2010. p. 15–60.
14.
go back to reference Weiss A, Domig KJ, Kneifel W. Comparison of selective media for the enumeration of probiotic enterococci from animal feed. Food Technol Biotechnol. 2005;43(2):147–55. Weiss A, Domig KJ, Kneifel W. Comparison of selective media for the enumeration of probiotic enterococci from animal feed. Food Technol Biotechnol. 2005;43(2):147–55.
15.
go back to reference Organization, W.H. Basic laboratory procedures in clinical bacteriology; 2003. p. 2–150. Organization, W.H. Basic laboratory procedures in clinical bacteriology; 2003. p. 2–150.
16.
go back to reference Dong D, et al. Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium Difficile from a Chinese tertiary hospital. Int J Antimicrob Agents. 2013;41(1):80–4.CrossRefPubMed Dong D, et al. Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium Difficile from a Chinese tertiary hospital. Int J Antimicrob Agents. 2013;41(1):80–4.CrossRefPubMed
17.
go back to reference Olawale KO, Fadiora SO, Taiwo SS. Prevalence of hospital acquired enterococci infections in two primary-care hospitals in Osogbo, Southwestern Nigeria. Afr J Infect Dis. 2011;5(2):40–6.PubMedPubMedCentral Olawale KO, Fadiora SO, Taiwo SS. Prevalence of hospital acquired enterococci infections in two primary-care hospitals in Osogbo, Southwestern Nigeria. Afr J Infect Dis. 2011;5(2):40–6.PubMedPubMedCentral
18.
go back to reference Salem-Bekhit MM, et al. Increasing prevalence of high-level gentamicin resistant enterococci: an emerging clinical problem. Afr J Microbiol Res. 2011;5(31):5713–20. Salem-Bekhit MM, et al. Increasing prevalence of high-level gentamicin resistant enterococci: an emerging clinical problem. Afr J Microbiol Res. 2011;5(31):5713–20.
19.
go back to reference Kimando J, Okemo P, Njagi E. Resistance to antibiotics in urinopathogenic bacteria isolated in patients attending Kenyatta university health clinic, Nairobi. East Afr Med J. 2010;87(3):115–9.CrossRefPubMed Kimando J, Okemo P, Njagi E. Resistance to antibiotics in urinopathogenic bacteria isolated in patients attending Kenyatta university health clinic, Nairobi. East Afr Med J. 2010;87(3):115–9.CrossRefPubMed
20.
go back to reference Abrha A, et al. Bacteraemia among severely malnourished children in jimma university hospital, ethiopia. Ethiop J Health Sci. 2011;21(3):175–82.PubMedPubMedCentral Abrha A, et al. Bacteraemia among severely malnourished children in jimma university hospital, ethiopia. Ethiop J Health Sci. 2011;21(3):175–82.PubMedPubMedCentral
21.
go back to reference Melaku S, et al. Antibiogram of nosocomial urinary tract infections in Felege Hiwot referral hospital, Ethiopia. Afr Health Sci. 2012;12(2):134–9.PubMedPubMedCentral Melaku S, et al. Antibiogram of nosocomial urinary tract infections in Felege Hiwot referral hospital, Ethiopia. Afr Health Sci. 2012;12(2):134–9.PubMedPubMedCentral
22.
go back to reference Gizachew Y, et al. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. European Journal of Experimental Biology. 2012;2(4):889–98. Gizachew Y, et al. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. European Journal of Experimental Biology. 2012;2(4):889–98.
23.
go back to reference Adhikari L. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Global Infect Dis. 2010;2(3):231.CrossRef Adhikari L. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Global Infect Dis. 2010;2(3):231.CrossRef
24.
go back to reference El-Din RAA, El-Mahdy HS. Molecular characterization of enterococcus strains isolated from cases of neonatal sepsis in neonatal intensive care unit. Afr J Microbiol Res. 2013;6(44):7206–11. El-Din RAA, El-Mahdy HS. Molecular characterization of enterococcus strains isolated from cases of neonatal sepsis in neonatal intensive care unit. Afr J Microbiol Res. 2013;6(44):7206–11.
25.
go back to reference Yismaw G, et al. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients. European Journal of Experimental Biology. 2012;2(4):889–98. Yismaw G, et al. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients. European Journal of Experimental Biology. 2012;2(4):889–98.
26.
go back to reference Gunasekera S, Perera J. Drug resistant enterococci: factors associated with gastrointestinal tract colonization. Ceylon J Med Sci. 2008;50(1):9–14.CrossRef Gunasekera S, Perera J. Drug resistant enterococci: factors associated with gastrointestinal tract colonization. Ceylon J Med Sci. 2008;50(1):9–14.CrossRef
27.
go back to reference Chabuck Z, Charrakh A, Al-Saadi M. Prevalence of vancomycin resistant enterococci in Hilla. Med J Babylon. 2011:326–40. Chabuck Z, Charrakh A, Al-Saadi M. Prevalence of vancomycin resistant enterococci in Hilla. Med J Babylon. 2011:326–40.
28.
go back to reference Mira M-U, et al. Prevalence of different enterococcal species isolated from blood and their susceptibility to antimicrobial drugs in Vojvodina, Serbia, 2011-2013. Afr J Microbiol Res. 2014;8(8):819–24.CrossRef Mira M-U, et al. Prevalence of different enterococcal species isolated from blood and their susceptibility to antimicrobial drugs in Vojvodina, Serbia, 2011-2013. Afr J Microbiol Res. 2014;8(8):819–24.CrossRef
29.
go back to reference Barros M, Martinelli R, Rocha H. Enterococcal urinary tract infections in a university hospital: clinical studies. Braz J Infect Dis. 2009;13(4):294–6.CrossRefPubMed Barros M, Martinelli R, Rocha H. Enterococcal urinary tract infections in a university hospital: clinical studies. Braz J Infect Dis. 2009;13(4):294–6.CrossRefPubMed
30.
go back to reference Fortún J, et al. Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. J Antimicrob Chemother. 2002;50(6):1003–9.CrossRefPubMed Fortún J, et al. Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. J Antimicrob Chemother. 2002;50(6):1003–9.CrossRefPubMed
31.
go back to reference Reuken P, et al. Emergence of spontaneous bacterial peritonitis due to enterococci–risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther. 2012;35(10):1199–208.CrossRefPubMed Reuken P, et al. Emergence of spontaneous bacterial peritonitis due to enterococci–risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther. 2012;35(10):1199–208.CrossRefPubMed
Metadata
Title
Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital
Authors
Amelework Yilema
Feleke Moges
Sisay Tadele
Mengistu Endris
Afework Kassu
Wondwossen Abebe
Getnet Ayalew
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2363-3

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.